AMGEN INC Other Non-current Liabilities 2008-2026 | AMGN
Beta
What is AMGEN INC's current other non-current liabilities?
AMGEN INC (AMGN) annual other non-current liabilities for 2025 was $2.38B, a 1.23% increase from 2024. AMGEN INC other non-current liabilities for the quarter ending March 31, 2026 was $2.37B.
What was AMGEN INC's other non-current liabilities in 2024?
AMGEN INC annual other non-current liabilities for 2024 was $2.35B, a 0.99% increase from 2023.
What was AMGEN INC's other non-current liabilities in 2023?
AMGEN INC annual other non-current liabilities for 2023 was $2.33B, a 12.26% decline from 2022.
What is AMGEN INC's 5-year other non-current liabilities CAGR?
AMGEN INC other non-current liabilities grew at a compound annual growth rate (CAGR) of 3.29% from FY2020 to FY2025, going from $2.02B to $2.38B over 5 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+3.3%
FY2020
$2.02B
→
FY2025
$2.38B
080910111213141516171819202122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.38B | +1.2% | 10-K |
| FY2024 | $2.35B | +1.0% | 10-K |
| FY2023 | $2.33B | -12.3% | 10-K |
| FY2022 | $2.65B | +7.5% | 10-K |
| FY2021 | $2.46B | +21.8% | 10-K |
| FY2020 | $2.02B | -8.5% | 10-K |
| FY2019 | $2.21B | +72.3% | 10-K |
| FY2018 | $1.28B | +3.7% | 10-K |
| FY2017 | $1.24B | -17.4% | 10-K |
| FY2016 | $1.50B | +14.6% | 10-K |
| FY2015 | $1.31B | -48.6% | 10-K |
| FY2014 | $2.55B | -14.0% | 10-K |
| FY2013 | $2.96B | -1.7% | 10-K |
| FY2012 | $3.01B | +9.8% | 10-K |
| FY2011 | $2.74B | +30.8% | 10-K |
| FY2010 | $2.10B | -15.7% | 10-K |
| FY2009 | $2.49B | +8.0% | 10-K |
| FY2008 | $2.30B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →